Next-generation biomarkers for short term risk stratification in tricuspid valve intervention
{{output}}
Background: Interventional therapies for tricuspid regurgitation are rapidly evolving, yet optimal patient selection remains challenging. Conventional biomarkers such as NT-proBNP may inadequately reflect the complex pathophysiol... ...
